Dramatic growth being experienced by the nutraceuticals market is forecast to be the biggest driver in the development of the flavenoids and isoflavones markets in Europe in the next six years, according to new research. A report by international market analysts Frost and Sullivan reveals that the combined market, valued at $94million in 2000 will grow to be worth $144million by 2008.